Oncolytic virus immunotherapy has been proposed as a step forward for cancer treatment because it can kill cancer cells while activating the immune system. However, its current clinical application is ...
The FDA approved Regeneron Pharmaceuticals Inc's (NASDAQ:REGN) Veopoz (pozelimab-bbfg) for adult and pediatric patients one year of age and older with CHAPLE disease, known as CD55-deficient ...
We all forget things, and sometimes it would be better if we did not. Normal forgetting occurs more frequently as we age, but more serious, progressive, retrograde forgetting, which can have severe, ...
Hijacking host proteins for effective complement resistance By propagating SARS-CoV-2 in human cells the researchers discovered that the virus particles acquire the cellular proteins CD55 and CD59.
In a recent study posted to the bioRxiv* preprint server, researchers investigated the expression of complement regulatory proteins (CRPs) in coronavirus disease 2019 (COVID-19) to identify potential ...
Credit: Getty Images. CHAPLE disease is a rare genetic disorder caused by mutations in the CD55 gene. The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results